Innate Pharma's Expanded IO AstraZeneca Deal Jump-Starts US Ambitions

 
• By John Davis

France's Innate Pharma gets a boost to its plans to become a fully integrated biotech by forging a long-term immuno-oncology development partnership with AstraZeneca, and the setting up of a commercialization team in the US.  

Jump start
Expanded collaboration electrifies Innate's US commercial ambitions • Source: Shutterstock.

More from Immuno-oncology

More from Anticancer